BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15058748)

  • 21. Ocular ethambutol toxicity.
    Herchline TE
    Mayo Clin Proc; 2004 May; 79(5):701; author reply 701, 703. PubMed ID: 15132421
    [No Abstract]   [Full Text] [Related]  

  • 22. Progressive Vision Loss in a 62-Year-Old Woman.
    Vu DM; Swaminathan SS
    JAMA Ophthalmol; 2020 Nov; 138(11):1207-1208. PubMed ID: 32910149
    [No Abstract]   [Full Text] [Related]  

  • 23. Update on ethambutol optic neuropathy.
    Fraunfelder FW; Sadun AA; Wood T
    Expert Opin Drug Saf; 2006 Sep; 5(5):615-8. PubMed ID: 16907651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual function in recovered ethambutol optic neuropathy.
    Woung LC; Jou JR; Liaw SL
    J Ocul Pharmacol Ther; 1995; 11(3):411-9. PubMed ID: 8590273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical coherence tomography can monitor reversible nerve-fibre layer changes in a patient with ethambutol-induced optic neuropathy.
    Zoumalan CI; Sadun AA
    Br J Ophthalmol; 2007 Jun; 91(6):839-40. PubMed ID: 17510481
    [No Abstract]   [Full Text] [Related]  

  • 26. [Optic nerve damage caused by administration of ethambutol].
    Filipović T; Bujanić-Cuculić S; Bosković I
    Lijec Vjesn; 1997 Nov; 119(10):273-4. PubMed ID: 9531761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethambutol-induced optic neuropathy.
    Kyncl M; Fus M; Lestak J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Sep; 167(3):288-293. PubMed ID: 35582729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Optic nerve neuropathy by ethambutol toxicity].
    Chen L; Liang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):302-4. PubMed ID: 11775861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethambutol Optic Neuropathy: Vigilance and Screening, the Keys to Prevent Blindness with the Revised Anti-tuberculous Therapy Regimen.
    Saxena R; Phuljhele S; Prakash A; Lodha R; Singh D; Karna S; Mohan A; Gandhi R; Menon V; Garg R; The Inosrg
    J Assoc Physicians India; 2021 Feb; 69(2):54-57. PubMed ID: 33527812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifocal electroretinogram demonstrated macular toxicity associated with ethambutol related optic neuropathy.
    Lai TY; Chan WM; Lam DS; Lim E
    Br J Ophthalmol; 2005 Jun; 89(6):774-5. PubMed ID: 15923521
    [No Abstract]   [Full Text] [Related]  

  • 31. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy.
    Chai SJ; Foroozan R
    Br J Ophthalmol; 2007 Jul; 91(7):895-7. PubMed ID: 17215265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethambutol-induced optic neuropathy in nontuberculous mycobacterial disease.
    Yang S; Falardeau J; Winthrop KL; Henkle E
    Int J Tuberc Lung Dis; 2021 Aug; 25(8):680-682. PubMed ID: 34330358
    [No Abstract]   [Full Text] [Related]  

  • 33. Ethambutol-associated optic neuropathy.
    Lim SA
    Ann Acad Med Singap; 2006 Apr; 35(4):274-8. PubMed ID: 16710500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Visual impairment due to optic neuropathy in 2 patients on amiodarone, and ethambutol and isoniazide therapy, respectively].
    Verslegers W; De Deyn PP
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1872. PubMed ID: 11593793
    [No Abstract]   [Full Text] [Related]  

  • 35. Structural-functional dissociation in presumed ethambutol optic neuropathy.
    Masvidal D; Parrish RK; Lam BL
    J Neuroophthalmol; 2010 Dec; 30(4):305-10. PubMed ID: 20592624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drastically Progressive Ethambutol-induced Optic Neuropathy after Withdrawal of Ethambutol: A Case Report and Literature Review.
    Matsumoto T; Kusabiraki R; Arisawa A; Fujiki T; Noda A; Tanaka A; Yamamoto N; Aihara K; Yamaoka S; Mishima M
    Intern Med; 2021 Jun; 60(11):1785-1788. PubMed ID: 33390493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of treatment with ethambutol and capreomycin in chronic pulmonary tuberculosis.
    Kozakow H; Potworowska M; Janowiec M; Klimkiewicz H; Niemirowski J; Pszonicka A; Pecyna-Sielewicz J; Polaczek E; Rykowska Z; Frenkel A
    Pol Med J; 1970; 9(4):876-85. PubMed ID: 4991068
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea.
    Lee EJ; Kim SJ; Choung HK; Kim JH; Yu YS
    J Neuroophthalmol; 2008 Dec; 28(4):269-77. PubMed ID: 19145123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of visual function for early detection of ethambutol toxicity.
    Menon V; Jain D; Saxena R; Sood R
    Br J Ophthalmol; 2009 Sep; 93(9):1251-4. PubMed ID: 19525243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disentangling renal function in the context of irreversible ethambutol optic neuropathy.
    Chatziralli IP; Papazisis L; Keryttopoulos P; Papadopoulou D; Sergentanis TN
    Int Ophthalmol; 2010 Dec; 30(6):743-4. PubMed ID: 20111890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.